10x Genomics, Inc. TXG Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s increase (decrease) in other operating assets?
- 10x Genomics, Inc. (TXG) reported increase (decrease) in other operating assets of -$282K in Q1 2026.
- How has 10x Genomics, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- 10x Genomics, Inc.'s increase (decrease) in other operating assets increased by 87.8% year-over-year, from -$2.31M to -$282K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.